Shigehiro Koganemaru

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Endoscopic Submucosal Dissection

Induced Pluripotent Stem Cells

Top Venues

Cancer research communications

Pharmaceuticals (Basel, Switzerland)

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shigehiro Koganemaru, Hirobumi Fuchigami, Daiki Yamashita, Chihiro Morizono, Hironori Sunakawa, Akihito Kawazoe, Yoshiaki Nakamura, Yasutoshi Kuboki, Kohei Shitara, Tomonori Yano, Toshihiko Doi, Masahiro Yasunaga
Quantitative analysis of the concentration of FTD in tumor hypoxic regions using a novel platform combining functional endoscopy and mass spectrometry. Clinical pharmacology and therapeutics (2023)
Yoshikatsu Koga, Hiroki Takashima, Shigehiro Koganemaru
Special Issue: Evaluation of the Antitumor Mechanism of Armed Antibodies. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Yoshikatsu Koga, Hiroki Takashima, Shigehiro Koganemaru
Special Issue: Evaluation of the Antitumor Mechanism of Armed Antibodies. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Yasutoshi Kuboki, Toshio Shimizu, Kan Yonemori, Takashi Kojima, Shunsuke Kondo, Shigehiro Koganemaru, Satoru Iwasa, Kenichi Harano, Takafumi Koyama, Vickie Lu, Xiaofei Zhou, Huifeng Niu, Tomoko Yanai, Ignacio Garcia-Ribas, Toshihiko Doi, Noboru Yamamoto
Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study. Cancer research communications 2 (11) (2022)
Yasutoshi Kuboki, Toshio Shimizu, Kan Yonemori, Takashi Kojima, Shunsuke Kondo, Shigehiro Koganemaru, Satoru Iwasa, Kenichi Harano, Takafumi Koyama, Vickie Lu, Xiaofei Zhou, Huifeng Niu, Tomoko Yanai, Ignacio Garcia-Ribas, Toshihiko Doi, Noboru Yamamoto
Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study. Cancer research communications 2 (11) (2022)
Shigehiro Koganemaru, Naoko Inoshita, Yuji Miura, Yu Miyama, Yudai Fukui, Yukinori Ozaki, Kenji Tomizawa, Yutaka Hanaoka, Shigeo Toda, Koichi Suyama, Yuko Tanabe, Jin Moriyama, Takeshi Fujii, Shuichiro Matoba, Hiroya Kuroyanagi, Toshimi Takano
Prognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancer. Cancer science 108 (5) (2017)